EFG Asset Management North America Corp. boosted its stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 103.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 45,647 shares of the company’s stock after purchasing an additional 23,247 shares during the quarter. EFG Asset Management North America Corp. owned about 0.05% of HealthEquity worth $4,382,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of HQY. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity in the fourth quarter valued at $26,000. Smartleaf Asset Management LLC lifted its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after purchasing an additional 98 shares during the last quarter. Proficio Capital Partners LLC bought a new position in HealthEquity during the fourth quarter valued at $39,000. UMB Bank n.a. grew its stake in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ increased its holdings in shares of HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after buying an additional 445 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages recently commented on HQY. JMP Securities increased their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Raymond James raised their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. KeyCorp cut their target price on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Monday. Mizuho assumed coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target for the company. Finally, Barrington Research reiterated an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday, March 14th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $113.69.
HealthEquity Trading Up 6.4 %
NASDAQ HQY opened at $90.32 on Tuesday. The stock has a market cap of $7.81 billion, a P/E ratio of 82.86, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a fifty day simple moving average of $104.67 and a two-hundred day simple moving average of $95.84.
Insider Buying and Selling
In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.20% of the stock is currently owned by company insiders.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- What is a Low P/E Ratio and What Does it Tell Investors?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- How to Calculate Options Profits
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- The 3 Best Retail Stocks to Shop for in August
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.